Pancreatic Cystic Neoplasms
IPMN Intercative Algorithms
International Consensus Guidelines (2006)
International Consensus Guidelines (2012)
European Experts Consensus (2013)
International Consensus Guidelines (2017)
European Evidence-Based Guidelines (2018)
International Consensus Guidelines (2024)
Consensus, Guidelines & Selected Articles
- International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology 24 (2024) 255e270
- Optimal Surveillance Interval of Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas. JAMA Surg. 2024;159(4):389-396
- Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation. Gastroenterology 2023;-:1–10
- It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy. HPB 2023;25(7),747-757
- Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinoma. European Journal of Surgical Oncology 49 (2023) 113e121
- Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice— Results From an International Survey. Gastroenterology 2021;160:2234–2238
- Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report. Dig Surg 2021;38:316–322
- State‐of‐the‐art surgical treatment of IPMNs. Langenbeck's Archives of Surgery (2021) 406:2633–2642
- Fukuoka-Negative Branch-Duct IPMNs: When to Worry? A Study from the French Surgical Association (AFC). Ann Surg Oncol 2018 25(4):1017-1025
- ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. American Journal of Gastroenterology 113(4):p 464-479, April 2018.
- European evidence-based guidelines on pancreatic cystic neoplasms The European Study Group on Cystic Tumours of the Pancreas. Gut 2018;67:789–804
- Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017 Sep-Oct;17(5):738-753.
- Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience. Ann Surg Oncol (2017) 24:1120–1126
- PATHOLOGIC EVALUATION AND REPORTING OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS (IPMNs) OF THE PANCREAS AND OTHER TUMORAL INTRAEPITHELIAL NEOPLASMS OF PANCREATOBILIARY TRACT: RECOMMENDATIONS OF VERONA CONSENSUS MEETING. Ann Surg. 2016 ; 263(1): 162–177
- Main-duct Intraductal Papillary Mucinous Neoplasm High Cancer Risk in Duct Diameter of 5 to 9 mm. Ann Surg 2015;262:875–881
- American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts. Gastroenterology 2015;148:819–822
- Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Digestive and Liver Disease 46 (2014) 479–493
- European experts consensus statement on cystic tumours of the pancreas. Digestive and Liver Disease 45 (2013) 703–711
- International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012 May-Jun;12(3):183-97
- International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6(1-2):17-32
This page is designed only for learning support purposes.
It is not dedicated for any medical use or patient care.
HBPSurG makes no claims of the accuracy of the information contained herein.
